Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer N Choi

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Dermatology Online Journal|November 19, 2019
Bullous dermatoses secondary to anti-PD-L1 agents: a case report and review of the literatureCory Kosche, Joshua L Owen, Lauren M Sadowsky, et al.
Journal of the American Academy of Dermatology|September 30, 2019
Current evidence for safety and efficacy of anti-programmed cell-death 1 agents in the treatment of cutaneous squamous cell carcinoma: A systematic reviewLauren M Sadowsky, Cory Kosche, Dennis P West, et al.
JAMA Dermatology|October 29, 2015
Cutaneous Vasculopathy as an Adverse Effect of the Anti-Vascular Endothelial Growth Factor Agent AxitinibVeronica J Shi, Anjela Galan, Ian D Odell, et al.
JAAD Case Reports|January 24, 2019
Rare case of leukemia cutis presenting as erythroderma in a patient with acute myeloid leukemiaMarie Donaldson, Matthew I Ebia, Joshua L Owen, et al.
The British Journal of Dermatology|October 15, 2025
Chimeric antigen receptor T-cell therapy-related T-cell malignancies: raising awareness of cutaneous manifestationsJonathan J Park, Cuong V Nguyen, Jennifer N Choi, et al.
JAAD Case Reports|September 7, 2022
Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapySalma El-Behaedi, Spencer Ng, Parul K Goyal, et al.
Archives of Dermatological Research|September 12, 2023
Protocol for a feasibility trial (EXPRESS-C-GVHD) for an expressive helping intervention within a support group for cutaneous graft-versus-host-diseaseTrisha Kaundinya, Yae Kye, Salma E El-Behaedi, et al.
Dermatologic Clinics|August 31, 2019
Cutaneous Adverse Reactions of Anticancer AgentsSubuhi Kaul, Benjamin H Kaffenberger, Jennifer N Choi, et al.
Frontiers in Oncology|October 16, 2018
Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B PhototherapyMarie Donaldson, Joshua L Owen, Young K Chae, et al.
JAMA Dermatology|December 18, 2015
Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic MelanomaMariam B Totonchy, Harib H Ezaldein, Christine J Ko, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Dermatology Online Journal|November 19, 2019
Bullous dermatoses secondary to anti-PD-L1 agents: a case report and review of the literatureCory Kosche, Joshua L Owen, Lauren M Sadowsky, et al.
Journal of the American Academy of Dermatology|September 30, 2019
Current evidence for safety and efficacy of anti-programmed cell-death 1 agents in the treatment of cutaneous squamous cell carcinoma: A systematic reviewLauren M Sadowsky, Cory Kosche, Dennis P West, et al.
JAMA Dermatology|October 29, 2015
Cutaneous Vasculopathy as an Adverse Effect of the Anti-Vascular Endothelial Growth Factor Agent AxitinibVeronica J Shi, Anjela Galan, Ian D Odell, et al.
JAAD Case Reports|January 24, 2019
Rare case of leukemia cutis presenting as erythroderma in a patient with acute myeloid leukemiaMarie Donaldson, Matthew I Ebia, Joshua L Owen, et al.
The British Journal of Dermatology|October 15, 2025
Chimeric antigen receptor T-cell therapy-related T-cell malignancies: raising awareness of cutaneous manifestationsJonathan J Park, Cuong V Nguyen, Jennifer N Choi, et al.
JAAD Case Reports|September 7, 2022
Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapySalma El-Behaedi, Spencer Ng, Parul K Goyal, et al.
Archives of Dermatological Research|September 12, 2023
Protocol for a feasibility trial (EXPRESS-C-GVHD) for an expressive helping intervention within a support group for cutaneous graft-versus-host-diseaseTrisha Kaundinya, Yae Kye, Salma E El-Behaedi, et al.
Dermatologic Clinics|August 31, 2019
Cutaneous Adverse Reactions of Anticancer AgentsSubuhi Kaul, Benjamin H Kaffenberger, Jennifer N Choi, et al.
Frontiers in Oncology|October 16, 2018
Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B PhototherapyMarie Donaldson, Joshua L Owen, Young K Chae, et al.
JAMA Dermatology|December 18, 2015
Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic MelanomaMariam B Totonchy, Harib H Ezaldein, Christine J Ko, et al.
Pageof 9